{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:45:23Z","timestamp":1775889923649,"version":"3.50.1"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:p>OBJECTIVE. We describe the evaluation and treatment of neonatal community-acquired Staphylococcus aureus disease in the era of community-acquired methicillin-resistant S aureus.<\/jats:p>\n               <jats:p>METHODS. We retrospectively reviewed the evaluation and treatment of 126 community-acquired S aureus infections of term and late-preterm previously healthy neonates who were \u226430 days of age between August 2001 and July 2006 at Texas Children's Hospital.<\/jats:p>\n               <jats:p>RESULTS. S aureus infections included 43 pustulosis, 68 cellulitis\/abscess, and 15 invasive infections. We found 84 methicillin-resistant and 42 methicillin-susceptible S aureus isolates. Twenty-one patients received outpatient antibiotics before hospital presentation. Systemic infection evaluation included urine, blood, and cerebrospinal fluid cultures in 79, 102, and 84 neonates, respectively. Culture revealed S aureus urinary tract infections in 1, S aureus bacteremias in 6, and aseptic cerebrospinal fluid pleocytosis of unclear cause in 11 neonates. Physicians admitted 106, transferred 5 to other hospitals, and discharged 15 afebrile patients with topical or oral antibiotics. Clindamycin was the predominant antistaphylococcal intravenous and oral antibiotic for pustulosis and cellulitis\/abscess infections. One patient with systemic S aureus and herpes simplex virus infection died. At discharge after inpatient treatment, physicians prescribed no antibiotics for 43 patients and oral or topical antibiotics for 62 patients. Outpatient treatment failed for 1 patient who was discharged after intravenous therapy and was readmitted. Eighty percent (16 of 20) of patients with mastitis alone completed treatment with outpatient oral antibiotics.<\/jats:p>\n               <jats:p>CONCLUSIONS. Evaluation and treatment strategies for neonatal community-acquired S aureus disease are varied at our hospital. Prospective studies are needed to determine optimal management strategies.<\/jats:p>","DOI":"10.1542\/peds.2007-0956","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T17:08:45Z","timestamp":1193936925000},"page":"937-945","source":"Crossref","is-referenced-by-count":63,"title":["Evaluation and Treatment of Community-Acquired <i>Staphylococcus aureus<\/i> Infections in Term and Late-Preterm Previously Healthy Neonates"],"prefix":"10.1542","volume":"120","author":[{"given":"Regine M.","family":"Fortunov","sequence":"first","affiliation":[{"name":"Department of Pediatrics"},{"name":"Sections of Neonatology"},{"name":"Infectious Diseases, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina G.","family":"Hulten","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Department of Neonatology"},{"name":"Infectious Disease Service, Texas Children's Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Hammerman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Department of Neonatology"},{"name":"Infectious Disease Service, Texas Children's Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edward O.","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Department of Neonatology"},{"name":"Infectious Disease Service, Texas Children's Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon L.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Department of Neonatology"},{"name":"Infectious Disease Service, Texas Children's Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2022051611570161900_R1","doi-asserted-by":"crossref","unstructured":"Orscheln RC, Shinefield HR, St Geme JW 3rd. Staphylococcal infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006:512\u2013543","DOI":"10.1016\/B0-72-160537-0\/50019-0"},{"key":"2022051611570161900_R2","doi-asserted-by":"crossref","unstructured":"Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis.\u20082004;39:1460\u20131466","DOI":"10.1086\/425321"},{"key":"2022051611570161900_R3","doi-asserted-by":"crossref","unstructured":"Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics.\u20082006;118:874\u2013881","DOI":"10.1542\/peds.2006-0884"},{"key":"2022051611570161900_R4","doi-asserted-by":"crossref","unstructured":"Laibl VR, Sheffield JS, Roberts S, McIntire DD, Trevino S, Wendel GD Jr. Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. Obstet Gynecol.\u20082005;106:461\u2013465","DOI":"10.1097\/01.AOG.0000175142.79347.12"},{"key":"2022051611570161900_R5","doi-asserted-by":"crossref","unstructured":"Reddy P, Qi C, Zembower T, Noskin GA, Bolon M. Postpartum mastitis and community-acquired methicillin-resistant Staphylococcus aureus. Emerg Infect Dis.\u20082007;13:298\u2013301","DOI":"10.3201\/eid1302.060989"},{"key":"2022051611570161900_R6","doi-asserted-by":"crossref","unstructured":"Dehority W, Wang E, Vernon PS, Lee C, Perdreau-Remington F, Bradley J. Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate. Pediatr Infect Dis J.\u20082006;25:1080\u20131081","DOI":"10.1097\/01.inf.0000243158.25713.29"},{"key":"2022051611570161900_R7","unstructured":"Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns: Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep.\u20082006;55:329\u2013332"},{"key":"2022051611570161900_R8","unstructured":"Bradley J, Frenck R. CA-MRSA infections an increasing concern in early infancy. AAP News.\u20082006;27:16"},{"key":"2022051611570161900_R9","doi-asserted-by":"crossref","unstructured":"Mishaan AM, Mason EO Jr, Martinez-Aguilar G, et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J.\u20082005;24:201\u2013206","DOI":"10.1097\/01.inf.0000151107.29132.70"},{"key":"2022051611570161900_R10","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Testing: 17th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007"},{"key":"2022051611570161900_R11","doi-asserted-by":"crossref","unstructured":"Sarff LD, Platt LH, McCracken GH Jr. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr.\u20081976;88:473\u2013477","DOI":"10.1016\/S0022-3476(76)80271-5"},{"key":"2022051611570161900_R12","doi-asserted-by":"crossref","unstructured":"Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol.\u20081990;28:2059\u20132063","DOI":"10.1128\/jcm.28.9.2059-2063.1990"},{"key":"2022051611570161900_R13","doi-asserted-by":"crossref","unstructured":"Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J.\u20082006;25:349\u2013353","DOI":"10.1097\/01.inf.0000207404.50143.1e"},{"key":"2022051611570161900_R14","doi-asserted-by":"crossref","unstructured":"Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol.\u20081995;33:2233\u20132239","DOI":"10.1128\/jcm.33.9.2233-2239.1995"},{"key":"2022051611570161900_R15","doi-asserted-by":"crossref","unstructured":"Manroe BL, Rosenfeld CR, Weinberg AG, Browne R. The differential leukocyte count in the assessment and outcome of early-onset neonatal group B streptococcal disease. J Pediatr.\u20081977;91:632\u2013637","DOI":"10.1016\/S0022-3476(77)80522-2"},{"key":"2022051611570161900_R16","doi-asserted-by":"crossref","unstructured":"Syrogiannopoulos GA, Grivea IN, Anastassiou ED, Triga MG, Dimitracopoulos GO, Beratis NG. Sterile cerebrospinal fluid pleocytosis in young infants with urinary tract infection. Pediatr Infect Dis J.\u20082001;20:927\u2013930","DOI":"10.1097\/00006454-200110000-00003"},{"key":"2022051611570161900_R17","doi-asserted-by":"crossref","unstructured":"Ginsburg CM, McCracken GH Jr. Urinary tract infections in young infants. Pediatrics.\u20081982;69:409\u2013412","DOI":"10.1542\/peds.69.4.409"},{"key":"2022051611570161900_R18","unstructured":"American Academy of Pediatrics. Staphylococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:598\u2013610"},{"key":"2022051611570161900_R19","unstructured":"Autret E, Laugier J, Marimbu J, Vaillant MC, Furet Y, Breteau M. Comparison of plasma levels of amoxicillin administered by oral and intravenous routes in neonatal bacterial colonization [in French]. Arch Fr Pediatr.\u20081988;45:679\u2013682"},{"key":"2022051611570161900_R20","doi-asserted-by":"crossref","unstructured":"Boothman R, Kerr MM, Marshall MJ, Burland WL. Absorption and excretion of cephalexin by the newborn infant. Arch Dis Child.\u20081973;48:147\u2013150","DOI":"10.1136\/adc.48.2.147"},{"key":"2022051611570161900_R21","unstructured":"Lwin N, Collipp PJ. Absorption and tolerance of clindamycin-2-palmitate in infants below 6 months of age. Curr Ther Res Clin Exp.\u20081970;12:648\u2013657"},{"key":"2022051611570161900_R22","unstructured":"American Academy of Pediatrics. Table 4.2: Antibacterial drugs for newborn infants: dose (mg\/kg or U\/kg) and frequency of administration. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:751\u2013752"},{"key":"2022051611570161900_R23","doi-asserted-by":"crossref","unstructured":"Andersen DH, Blanc WA, Crozier DN, Silverman WA. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics.\u20081956;18:614\u2013625","DOI":"10.1542\/peds.18.4.614"},{"key":"2022051611570161900_R24","doi-asserted-by":"crossref","unstructured":"Johnson L, Sarmiento F, Blanc WA, Day R. Kernicterus in rats with an inherited deficiency of glucuronyl transferase. AMA J Dis Child.\u20081959;97:591\u2013608","DOI":"10.1001\/archpedi.1959.02070010593009"},{"key":"2022051611570161900_R25","doi-asserted-by":"crossref","unstructured":"Odell GB. Studies in kernicterus: I. The protein binding of bilirubin. J Clin Invest.\u20081959;38:823\u2013833","DOI":"10.1172\/JCI103864"},{"key":"2022051611570161900_R26","unstructured":"Zyvox. In: Sanborn KD, eds. Physicians\u2019 Desk Reference. 61st ed. Montvale, NJ: Thomson PDR; 2007:2652\u20132660"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/5\/937\/1031896\/zpe01107000937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/5\/937\/1031896\/zpe01107000937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T11:57:14Z","timestamp":1652702234000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/5\/937\/71104\/Evaluation-and-Treatment-of-Community-Acquired"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0956","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}